
Haemophilia A is the most common of the serious haemorrhagic diseases. It is caused by a deficiency in factor VIII (anti-haemophilia factor A) and affects around 1 in 5000 male infants at birth.
Haemophilia B is a disease caused by a congenital deficiency in factor IX (anti-haemophilia factor B) that affects around one in 30 000 male infants at birth.
Optimum analytical performance for even more reliable patient results is achieved thanks to an extended working range with a unique calibration curve, perfect correlation of low patient results and very good precision on the entire working range.
Adapted reagents whatever the clinical context, especially for the diagnosis and monitoring of haemophilia
- Reagents on board stability extended to 8 hours
- Stability and robustness of calibrations: no systematic calibration needed
Efficient reagents for an easier laboratory practice
These reagents comply with current international guidelines:
- Calibrators & controls assayed against WHO International Standards for standardized results
- Residual activity of immunodepleted factor < 1% ensures reliability of patient's for low results
- Other coagulation factors at normal levels for specific measurements
- Addition of VWF (STA®-ImmunoDef VIII) adapted to Bethesda and Nijmegen inhibitor assays
STA®-ImmunoDef VIII – Cat. Nr.00728 | STA®-ImmunoDef IX – Cat. Nr. 00734 | |
---|---|---|
Packaging | 6 x 1 mL | 6 x 1 mL |
APTT reagents | STA® - C.K. Prest® (Cat.Nr. 00597) | STA® - C.K. Prest® (Cat.Nr. 00597) |
Calibrator | STA®-Unicalibrator (Cat.Nr. 00675) | STA®-Unicalibrator (Cat.Nr. 00675) |
Quality Control | STA®-System Control N & P (Cat.Nr. 00678) | STA®-System Control N & P (Cat.Nr. 00678) |
On board stability for STA-R and STA-Compact line analyzers | 8 h | 8 h |
Working range on STA-R and STA-Compact line analyzers | 0.7 – 400% | 0.7 – 300% |
* Availability depending upon the country